A new research has claimed that a defect in a single gene was responsible for oesophageal cancer in people carrying the rare inherited condition called Tylosis.

The RHBDF2 gene made people at high risk of the disease, according to researchers at the Queen Mary, University of London. The gene could offer a new is of study for developing cures for treating the disease.

Prof David Kelsell who led the study at Queen Mary’s said, “Finding a genetic cause for this aggressive cancer and understanding what that gene is doing is an enormous step forward.”

He also said that studying the complex biology that causes a particular cancer shows that the researchers now understand which type of treatment might be useful in treating the disease. About 8,000 people a year in the UK are affected by the disease, which is higher than any country in Europe.

Researchers did not have enough knowledge about how the disease develops or what types of drugs must be used in treatment. The new research provides new important information, which will be helpful in developing new cures for the disease.